Your trusted destination for CME, CPD & Medical Education across the Middle East.
University of Modena and Reggio Emilia (UNIMORE) & University Hospital of Modena, Modena, Italy
Prof. Antonio La Marca is a Professor of Obstetrics and Gynecology at the University of Modena and Reggio Emilia and the Director of the Clinic of Obstetrics and Gynecology at the University Hospital of Modena in Italy. He earned his Medical Doctorate (MD) and completed postgraduate residency training in Obstetrics and Gynecology, followed by a PhD in Reproductive Medicine, establishing himself as a world-renowned authority in human reproductive endocrinology and assisted reproductive technology (ART). Throughout his academic and clinical career, Prof. La Marca has spearheaded key advancements in ovarian reserve testing, individualization of controlled ovarian stimulation (COS), and non-invasive markers of oocyte quality. He was among the pioneering researchers to establish anti-Müllerian hormone (AMH) and antral follicle count (AFC) as primary predictors of ovarian response in IVF cycles, contributing to the clinical algorithms used globally in reproductive medicine today.Prof. La Marca is a prolific scientist, having authored or co-authored over 200 peer-reviewed scientific publications in top-tier medical journals, including Human Reproduction, Fertility and Sterility, and Reproductive BioMedicine Online. He has contributed to international clinical practice guidelines, including European Society of Human Reproduction and Embryology (ESHRE) task forces, and serves as a consultant for national health authorities on female fertility preservation and ART policies. As a featured international speaker for the 2nd Trust Fertility & Gynecology Conference 2026, Prof. La Marca brings extensive clinical and academic expertise to the Middle Eastern medical community. His presentations center on individualizing gonadotropin dosing, managing patients with poor ovarian reserve, and integrating novel pharmacological strategies to optimize live birth rates in complex IVF scenarios.
